These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21866108)

  • 1. The effect of treatment on monocyte and lymphocyte cytokine release in patients with aldosteronoma.
    Krysiak R; Okopien B
    Hypertens Res; 2012 Jan; 35(1):123-5. PubMed ID: 21866108
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
    Karagiannis A; Tziomalos K; Kakafika AI; Athyros VG; Harsoulis F; Mikhailidis DP
    Endocr Relat Cancer; 2008 Sep; 15(3):693-700. PubMed ID: 18586836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eplerenone use in primary aldosteronism during pregnancy.
    Cabassi A; Rocco R; Berretta R; Regolisti G; Bacchi-Modena A
    Hypertension; 2012 Feb; 59(2):e18-9. PubMed ID: 22146514
    [No Abstract]   [Full Text] [Related]  

  • 4. Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension.
    Ardhanari S; Kannuswamy R; Chaudhary K; Lockette W; Whaley-Connell A
    Adv Chronic Kidney Dis; 2015 May; 22(3):185-95. PubMed ID: 25908467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary aldosteronism.
    Ganguly A
    N Engl J Med; 1998 Dec; 339(25):1828-34. PubMed ID: 9854120
    [No Abstract]   [Full Text] [Related]  

  • 6. Robotic-assisted resection of adrenal aldosteronoma.
    Galvani C; Gorodner MV; Joseph Espat N
    Ann Surg Oncol; 2011 Feb; 18(2):479-81. PubMed ID: 20734146
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone.
    Wu CH; Yang YW; Hung SC; Tsai YC; Hu YH; Lin YH; Chu TS; Wu KD; Wu VC
    Sci Rep; 2015 Oct; 5():15297. PubMed ID: 26477337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension.
    Colussi G; Catena C; Sechi LA
    J Hypertens; 2013 Jan; 31(1):3-15. PubMed ID: 23011526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual case of an aldosterone-producing adrenocortical adenoma presenting with rhabdomyolysis.
    Karagüzel G; Bahat E; Imamoğlu M; Ahmetoğlu A; Yildiz K; Okten A
    J Pediatr Endocrinol Metab; 2009 Nov; 22(11):1087-90. PubMed ID: 20101896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
    Moore TD; Nawarskas JJ; Anderson JR
    Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas.
    Wang B; Zhang G; Ouyang J; Deng X; Shi T; Ma X; Li H; Ju Z; Wang C; Wu Z; Liu S; Zhang X
    Urology; 2010 Oct; 76(4):1018.e1-7. PubMed ID: 20708777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma.
    Amar L; Lorthioir A; Azizi M; Plouin PF
    Eur J Endocrinol; 2015 Mar; 172(3):R125-9. PubMed ID: 25315875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma.
    Zarnegar R; Young WF; Lee J; Sweet MP; Kebebew E; Farley DR; Thompson GB; Grant CS; Clark OH; Duh QY
    Ann Surg; 2008 Mar; 247(3):511-8. PubMed ID: 18376197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eplerenone: cardiovascular protection.
    Brown NJ
    Circulation; 2003 May; 107(19):2512-8. PubMed ID: 12756192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary hyperaldosteronism with adrenal adenoma or hyperplasia: surgical case or not?].
    Muller ME; Doenz F; Matter M; Wuerzner G; Burnier M
    Rev Med Suisse; 2013 Sep; 9(397):1633-4, 1636-8. PubMed ID: 24073475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage computed tomography-guided transhepatic radiofrequency ablation for unresected aldosteronoma of adrenohepatic fusion after adrenalectomy.
    Park JJ; Park BK; Kim JH; Jeong BC; Kim CK
    Int J Urol; 2016 Jan; 23(1):102-4. PubMed ID: 26415990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eplerenone for the treatment of cardiovascular disorders.
    Watanabe M; Krum H
    Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):831-8. PubMed ID: 22908915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroperitoneoscopic partial adrenalectomy for aldosterone-producing adenoma using an ultrasonically activated scalpel.
    Suzuki K; Sugiyama T; Saisu K; Ushiyama T; Fujita K
    Br J Urol; 1998 Jul; 82(1):138-9. PubMed ID: 9698680
    [No Abstract]   [Full Text] [Related]  

  • 20. [Conn's syndrome with adrenocortical adenoma. Action of spirolactone, SC-9420].
    GADRAT J; DELAUDE A; JORDA MF; MOREAU G
    Bull Mem Soc Med Hop Paris; 1962; 113():541-55. PubMed ID: 13896125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.